Compare · AMAG vs CATB

AMAG vs CATB

Side-by-side comparison of AMAG Pharmaceuticals, Inc. (AMAG) and Catabasis Pharmaceuticals, Inc. (CATB): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both AMAG and CATB operate in Major Pharmaceuticals (Health Care), so they compete in similar markets.
  • CATB has more recent analyst coverage (2 ratings vs 0 for AMAG).
MetricAMAGCATB
Company
AMAG Pharmaceuticals, Inc.
Catabasis Pharmaceuticals, Inc.
Price
-
-
Market cap
-
-
1M return
-
-
1Y return
-
-
Industry
Major Pharmaceuticals
Major Pharmaceuticals
Exchange
NASDAQ
NASDAQ
IPO
n/a
2015
News (4w)
0
0
Recent ratings
0
2
CATB

Catabasis Pharmaceuticals, Inc.

Catabasis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics in the United States. The company's lead product candidate is QLS-215, a monoclonal antibody inhibitor of plasma kallikrein that is in preclinical development for the treatment of hereditary angioedema, a rare, debilitating and potentially life-threatening disease. The company was incorporated in 2008 and is based in Boston, Massachusetts.

Latest AMAG

Latest CATB